Efficacy of Sodium‐Glucose Cotransporter‐2 Inhibitors in Patients With Acute Myocardial Infarction: A Meta‐Analysis of Randomised Controlled Trials

ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with or without Type 2 diabetes and heart failure (HF). However, studies have shown conflicting evidence regarding their efficacy in patients following acute myocardial infarction (...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Mushood Ahmed, Hritvik Jain, Hira Javaid, Areeba Ahsan, Szabolcs Szilagyi, Adeel Ahmad, Raheel Ahmed
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-09-01
Saila:	Endocrinology, Diabetes & Metabolism
Gaiak:	dapagliflozin empagliflozin myocardial infarction sodium‐glucose co‐transporter inhibitors
Sarrera elektronikoa:	https://doi.org/10.1002/edm2.514
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!